Pharming Group N.V. Fourth quarter and full year 2023 financial results March 14, 2024 NASDAQ: PHAR | EURONEXT Amsterdam: PHARM SPEAKERS Sijmen de Vries, MD Stephen Toor Anurag Relan, MD Jeroen Wakkerman Chief Executive Officer Chief Commercial Officer Chief Medical Officer Chief Financial Officer Forward-looking statements This presentation may contain forward-looking statements. Forward-looking statements are statements of future expectations that are based on management’s current expectations and assumpt ...